InvestSMART

Actinogen Medical Limited (ASX: ACW) - Announcements

Current share price for ACW : $0.046 0.001 (2.13%)+

ASX company news and announcements for Actinogen Medical Limited (ACW) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Actinogen Medical Limited (ACW) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Actinogen Medical Limited (ACW), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Actinogen Medical Limited (ACW)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$178 New Patents Allowed for B-HSD1 Inhibitor 5 Nov 2014 6:25PM $0.044 $0.046 risen by 4.55%
$178 Appendix 4C & Commentary 23 Oct 2014 5:49PM $0.044 $0.046 risen by 4.55%
$178 Capital Raising 27 Aug 2014 9:35AM $0.037 $0.046 risen by 24.32%
$178 Actinogen to acquire Corticrine Limited 27 Aug 2014 9:34AM $0.037 $0.046 risen by 24.32%
$178 Trading Halt 26 Aug 2014 9:51AM $0.039 $0.046 risen by 17.95%
$178 Appendix 4E & Financial Statements 1 Aug 2014 1:55PM $0.018 $0.046 risen by 155.56%
$178 Appendix 4C & Commentary 31 Jul 2014 1:05PM $0.018 $0.046 risen by 155.56%
$178 Actinogen Isolates Demonstrate Antitumorigenic Activity 13 Jun 2014 11:58AM $0.021 $0.046 risen by 119.05%
$178 Appendix 4C & Commentary 16 Apr 2014 12:40PM $0.030 $0.046 risen by 53.33%
$178 Appendix 4D & Half-Year Financial Statements 27 Feb 2014 7:42PM $0.024 $0.046 risen by 91.67%
$178 Actinogen & Curtin Uni to Work on Cancer Stem Cells 27 Feb 2014 3:19PM $0.024 $0.046 risen by 91.67%
$178 TRIALS RECOMMENCE ON ANTIBIOTIC PROJECT 12 Feb 2014 3:01PM $0.025 $0.046 risen by 84%
$178 Appendix 4C & Commentary 23 Jan 2014 3:45PM $0.027 $0.046 risen by 70.37%
$178 Leaf to Fund First Trial on Actingoen's Bioethanol Project 23 Dec 2013 8:26AM $0.022 $0.046 risen by 109.09%
$178 Placement, Appendix 3B & Section 708A Notice 12 Dec 2013 6:14PM $0.026 $0.046 risen by 76.92%
$178 R&D Tax Rebate Received 28 Nov 2013 3:53PM $0.015 $0.046 risen by 206.67%
$178 Activity Report & Appendix 4C 29 Oct 2013 9:46AM $0.007 $0.046 risen by 557.14%
$178 Closure of laboratory 12 Sep 2013 5:25PM $0.010 $0.046 risen by 360%
$178 Actinogen to receive further funding from Otsana Capital 11 Sep 2013 11:54AM $0.010 $0.046 risen by 360%
$178 Preliminary Final Report 30 Aug 2013 12:26PM $0.012 $0.046 risen by 283.33%
$178 Market Update and Clarification 29 Aug 2013 12:05PM $0.010 $0.046 risen by 360%
$178 Suspension of ACWN and ACWO 1/08/13 1 Aug 2013 8:55AM $0.017 $0.046 risen by 170.59%
$178 Appendix 4C - quarterly 31 Jul 2013 3:25PM $0.016 $0.046 risen by 187.50%
$178 Supplementary prospectus - withdrawal of offer 31 Jul 2013 3:21PM $0.016 $0.046 risen by 187.50%
$178 Rights Issue Prospectus 2 Jul 2013 8:27AM $0.010 $0.046 risen by 360%

826 - 850 of 915 results

Page 34 of 37

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.